Thursday, March 19, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

General Mills Faces Profit Squeeze Amid Strategic Price Cuts

Kennethcix by Kennethcix
March 19, 2026
in Analysis, Consumer & Luxury, Dow Jones, Earnings, S&P 500
0
General Mills Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

The American food conglomerate General Mills is navigating a cautious consumer environment by implementing strategic price reductions. While this move is designed to stimulate long-term sales volume, it has come at a significant short-term cost, severely impacting the company’s third-quarter earnings. The resulting profit decline has prompted several Wall Street analysts to revise their price targets downward for the company’s stock.

Earnings and Revenue Decline

For the recent quarter, General Mills reported a currency-adjusted adjusted earnings per share of $0.64, marking a steep 37% drop. Net sales also contracted, falling 8% to $4.4 billion. This performance was primarily driven by weakness in the North American retail and foodservice sectors, the company’s home market. Although the international and pet food segments posted growth, their gains were insufficient to offset the domestic losses. Investors reacted negatively to the news, sending the share price to a new 52-week low of 32.99 euros in yesterday’s trading session.

Should investors sell immediately? Or is it worth buying General Mills?

Margin Pressure and Analyst Revisions

The company’s adjusted gross margin fell by 280 basis points to 30.6%. Management attributed this compression to higher input costs and deliberate investments in both lower selling prices and brand marketing. The leadership is consciously accepting these near-term profitability hits with the goal of boosting sales volumes in the upcoming quarter. Citing persistent high selling, general, and administrative expenses, multiple investment banks have updated their outlooks:

  • BofA Securities: Lowered price target from $48 to $42 (Neutral rating)
  • Jefferies: Reduced price target from $42 to $37 (Hold rating)

Portfolio Restructuring Continues

Despite missing quarterly expectations, the management team reaffirmed its full fiscal 2026 outlook, which continues to project a decline in both organic net sales and adjusted operating profit. Concurrently, General Mills is advancing the restructuring of its brand portfolio. The sale of its Brazilian business, which includes the Yoki and Kitano brands, to 3corações is intended to free up resources. This divestiture allows the corporation to sharpen its focus on more profitable, global growth platforms moving forward.

Ad

General Mills Stock: Buy or Sell?! New General Mills Analysis from March 19 delivers the answer:

The latest General Mills figures speak for themselves: Urgent action needed for General Mills investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 19.

General Mills: Buy or sell? Read more here...

Tags: General Mills
Kennethcix

Kennethcix

Related Posts

Figma Stock
AI & Quantum Computing

Figma’s Profitability Challenge in the AI Era

March 19, 2026
Ocular Therapeutix Stock
Analysis

Ocular Therapeutix: Phase 3 Success for AXPAXLI Amidst Market Caution

March 19, 2026
Aemetis Stock
Analysis

Aemetis Shares Surge Amid Broader Biofuels Momentum

March 19, 2026
Next Post
Alibaba Stock

Alibaba's AI Ambition: A Costly Strategic Pivot

Coeur Mining Stock

Coeur Mining Shares Face Headwinds Amid Federal Reserve Policy Concerns

Eli Lilly Stock

Eli Lilly Commits Billions to Boost Production Amid Soaring Demand

Recommended

Marriott Stock

Marriott Stock: A Tale of Conflicting Market Signals

7 months ago
MSCI World ETF Stock

MSCI World ETF Faces Potential Shift as Market Dynamics Change

6 months ago
Salesforce Stock

Salesforce Accelerates AI Strategy with Acquisitions and Government Push

7 months ago
InnoCan Pharma Stock

InnoCan Pharma Shares Defy Logic with Sharp Decline

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Ciena’s Stock Surge: How 1.6T Technology Is Fueling Market Gains

Iqvia Forges AI Partnership with Nvidia to Transform Life Sciences

Aemetis Shares Surge Amid Broader Biofuels Momentum

Corvus Pharmaceuticals Secures Long-Term Financial Foundation

Institutional Buyers See Opportunity in Better Home Finance Stock

Lululemon Navigates Tariff Headwinds After Strong Quarter

Trending

AI & Quantum Computing

Institutional Investors Recalibrate Positions in AI Infrastructure Specialist Astera Labs

by Kennethcix
March 19, 2026
0

Significant portfolio adjustments are underway among major market participants holding shares of Astera Labs. The AI infrastructure...

Figma Stock

Figma’s Profitability Challenge in the AI Era

March 19, 2026
Ocular Therapeutix Stock

Ocular Therapeutix: Phase 3 Success for AXPAXLI Amidst Market Caution

March 19, 2026
Ciena Stock

Ciena’s Stock Surge: How 1.6T Technology Is Fueling Market Gains

March 19, 2026
Iqvia Stock

Iqvia Forges AI Partnership with Nvidia to Transform Life Sciences

March 19, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Institutional Investors Recalibrate Positions in AI Infrastructure Specialist Astera Labs
  • Figma’s Profitability Challenge in the AI Era
  • Ocular Therapeutix: Phase 3 Success for AXPAXLI Amidst Market Caution

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com